Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon

被引:51
作者
Pasquier, C
Njouom, R
Ayouba, A
Dubois, M
Sartre, MT
Vessière, A
Timba, I
Thonnon, J
Izopet, J
Nerrienet, E
机构
[1] Hop Purpan, Virol Lab, F-31059 Toulouse, France
[2] Ctr Pasteur Cameroun, Virol Lab, Yaounde, Cameroon
[3] Soc Camerounaise Gastroenterol, Yaounde, Cameroon
关键词
HCV; genetic variability; Cameroon; genotype; 4; NS5b gene;
D O I
10.1002/jmv.20468
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C virus infects humans world-wide. The virus genome varies greatly and it has several genotypes. HCV infection is highly prevalent in Central Africa and Cameroon. Initial studies on the genetic variability of HCV showed infection with HCV genotypes 1, 2, and 4. We have now sequenced the NS5b and E2 regions of 156 HCV isolates collected from patients presenting for diagnosis in Yaounde and used the data to describe the distribution of HCV genotypes and subtypes in patients with hepatitis in Cameroon. Genotype 1 was more frequent than Genotypes 4 and 2. Genotypes 1 and 4 were highly heterogeneous, containing many subtypes described previously (1b, 1c, le, 1h, 11, 4f, 4t, 4p, 4k) and unsubtyped groups. There was a systematic phylogenetic concordance between NS5b and E2 sequence clustering. The Genotype 2 sequences did not vary. Neither subject age nor gender influenced HCV distribution. HCV Genotypes 1 and 4 are very heterogeneous in Cameroon, perhaps due to ancient infections. The homogeneity of HCV Genotype 2 indicates its more recent introduction from western Africa.
引用
收藏
页码:390 / 398
页数:9
相关论文
共 40 条
[1]   Hepatitis c virus (HCV) infection in a community in the Nile Delta: Population description and HCV prevalence [J].
Abdel-Aziz, F ;
Habib, M ;
Mohamed, MK ;
Abdel-Hamid, M ;
Gamil, F ;
Madkour, S ;
Mikhail, NN ;
Thomas, D ;
Fix, AD ;
Strickland, GT ;
Anwar, W ;
Sallam, I .
HEPATOLOGY, 2000, 32 (01) :111-115
[2]   Distribution of hepatitis C genotype and co-infection rate with hepatitis G in Saudi Arabia [J].
Al-Knawy, B ;
Okamoto, H ;
El-Mekki, AA ;
Khalafalla, ME ;
Al Wabel, A ;
Qazi, F ;
Khan, A ;
Shatoor, A .
HEPATOLOGY RESEARCH, 2002, 24 (02) :95-98
[3]   Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa [J].
Candotti, D ;
Temple, J ;
Sarkodie, F ;
Allain, JP .
JOURNAL OF VIROLOGY, 2003, 77 (14) :7914-7923
[4]   GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS [J].
CHOO, QL ;
RICHMAN, KH ;
HAN, JH ;
BERGER, K ;
LEE, C ;
DONG, C ;
GALLEGOS, C ;
COIT, D ;
MEDINASELBY, A ;
BARR, PJ ;
WEINER, AJ ;
BRADLEY, DW ;
KUO, G ;
HOUGHTON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2451-2455
[5]   Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women [J].
Conte, D ;
Fraquelli, M ;
Prati, D ;
Colucci, A ;
Minola, E .
HEPATOLOGY, 2000, 31 (03) :751-755
[6]   Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C [J].
Davis, GL ;
Esteban-Mur, R ;
Rustgi, V ;
Hoefs, J ;
Gordon, SC ;
Trepo, C ;
Shiffman, ML ;
Zeuzem, S ;
Craxi, A ;
Ling, MH ;
Albrecht, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1493-1499
[7]   HEPATITIS-C IN REMOTE POPULATIONS OF SOUTHERN CAMEROON [J].
DELAPORTE, E ;
FROMENT, A ;
DAZZA, MC ;
HENZEL, D ;
LAROUZE, B .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1994, 88 (01) :97-98
[8]   The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt [J].
Frank, C ;
Mohamed, MK ;
Strickland, GT ;
Lavanchy, D ;
Arthur, RR ;
Magder, LS ;
El Khoby, T ;
Abdel-Wahab, Y ;
Ohn, EA ;
Anwar, W ;
Sallam, I .
LANCET, 2000, 355 (9207) :887-891
[9]  
Izopet J, 1998, J MED VIROL, V54, P86, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt
[10]  
86::AID-JMV3&gt